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ABSTRACT 
 
Investigating Dynamics of the STAT3 and C/EBPβ Pathways upon Stimulation by 
Inflammatory Cytokines. (April 2009) 
 
Peng Cheng 
Department of Chemical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Arul Jayaraman 
Department of Chemical Engineering 
 
The purpose of this project was to investigate the dynamics of the Jak-STAT3 (STAT3) 
and Erk-C/EBPβ (C/EBPβ) pathways upon stimulation with inflammatory cytokines 
such as Interleukin 6 (IL-6) and oncostatin M (OSM), which is also a member of the IL-
6 family. Green fluorescent protein (GFP) reporter plasmids with STAT3 and C/EBPβ 
transcription factor binding sequences were transfected into human hepatocarcinoma 
(HepG2) cells. Upon stimulation with inflammatory cytokines, the transcription factors 
STAT3 and C/EBPβ were activated and lead to the expression of GFP. The intensity of 
the observed fluorescence was proportional to the activation of the transcription factors 
and could be non-invasively monitored using fluorescence microscopy.  HepG2 cells 
with stably integrated reporter plasmids responsive to STAT3 and C/EBPβ into their 
genome exhibited a high signal-to-noise ratio. Our data showed that the expression of 
GFP (and hence, the activation of transcription factors) correlated with the specificity of 
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the cytokine used. Future work will focus on investigating (i) dynamics of STAT3 and 
C/EBPβ clones in response to different concentrations and durations of OSM stimulation 
and (ii) dynamics of STAT3 and C/EBPβ clones upon exposure to additional cytokines 
such as IL-10 and IL-1 that are likely to be present along with IL-6. 
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NOMENCLATURE 
 
GFP Green Fluorescence Protein 
Hr Hour 
OSM                                         Oncostatin M 
TF                                             Transcription Factor 
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CHAPTER I 
INTRODUCTION 
 
Cytokines, such as interleukin-6 (IL-6), are important in the onset and sustenance of the 
acute phase inflammatory response of the liver upon injury or inflammation [1]. Binding 
of IL-6 to its cell surface receptor (glycoprotein 130, gp130) leads to a series of 
intracellular molecular events that are collectively known as signal transduction. The end 
product of this signal transduction is the activation of transcription factors (TF). These 
events are instrumental in regulating the expression of target genes involved in the acute 
phase response. IL-6 signal transduction proceeds mainly through two pathways –Jak-
STAT3 and Erk- C/EBPβ [2, 3]. Examples of IL-6 regulated genes include plasma acute 
phase proteins (APPs) that are upregulated (e.g., C-reactive protein, haptoglobin, and 
serum amyloid A) as well as down-regulated (e.g., albumin and transferrin) [1]. Changes 
in the expression of these proteins are often used as indicators of the inflammatory 
response and its complications. In particular, the ratio of increase in C-reactive protein to 
decrease in albumin has been correlated to mortality of systematic inflammation [4]. 
Therefore, understanding the molecular mechanisms underlying the regulation of acute 
phase proteins could lead to novel approaches for the treatment of inflammatory 
diseases.  
 
 
 
_______________ 
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Figure 1. Schematic of IL-6 signal transduction pathways [5]. 
 
A detailed description of the STAT3 and C/EBPβ pathways is beyond the scope of this 
paper. Briefly, signaling through the STAT3 pathway upon IL-6 binding to gp130 leads 
to activation of the kinase JAK, which in turn activates (i.e., phosphorylates) the 
transcription factor STAT3 [1]. Activated STAT3 dimerizes and translocates into the 
nucleus to regulate gene expression. Given its important role in IL-6 signaling, STAT3 is 
chosen as representative molecule for monitoring activation through the Jak-STAT3 
pathway. The Erk-C/EBPβ pathway is initiated by binding of an adaptor protein SHP-2 
to a protein complex involving IL-6 and different receptors [1]. SHP-2 binding leads to 
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activation of kinases which eventually lead to activation of the transcription factor 
C/EBPβ (also known as NF-IL-6). Therefore, C/EBPβ is chosen as the indicator for the 
Erk-C/EBPβ pathway. Both pathways have negative feedback which serves to regulate 
activation of the two pathways. SOCS3, which is a protein up-regulated by STAT3 
itself, acts as an inhibitor of signal transduction through the Jak-STAT3 pathway [2, 3, 
6]. In addition, SOCS3 has also been speculated to impact signal transduction through 
the Erk-C/EBPβ pathway [7, 8]. Figure 1 is a brief demonstration of the mechanisms of 
the STAT3 and C/EBPβ pathways. 
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CHAPTER II 
METHODS 
 
Principle of GFP reporter system  
As shown in Figure 2, a low half-life (2hr) GFP was cloned into a plasmid under the 
control of a minimal promoter (CMVmin). When a TF bound to its upstream recognition 
sequence, the promoter was activated and GFP was expressed.  
 
Figure 2. Principle of GFP reporter systems. 
 
Reporter cell line generation 
Reporter plasmids for monitoring activation of STAT3 and C/EBPβ were introduced 
into HepG2 cells by electroporation. Approximately 5 x 106 cells were mixed with 10 µg 
of linearized plasmid (pSTAT3-d2egfp or pC/EBPβ-d2egfp) in a pre-chilled sterile 4-
mm electroporation cuvette and electroporated at 240V and 950 µF. Growth media (600 
µL) was immediately added to the cells after electropration and allowed to sit for 10 min 
at room temperature. The mixture was transferred to a 10 cm tissue culture dish and 
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incubated for 2 days prior to addition of 800 µg/mL of G418 as selection pressure. 
Surviving colonies (i.e., cells with the STAT3 or C/EBPβ reporter plasmid integrated 
into their genome) were selected and screened for induction of STAT3 or C/EBPβ 
activity after 3 weeks. 
 
Fluorescence microscopy 
HepG2 reporter cell lines for STAT3 and C/EBPβ were seeded in 24-well plates and 
exposed to 100 ng/mL of the cytokines IL-6 or OSM, respectively. The cell culture plate 
was placed on the incubated stage of a Zeiss Axiovert 200M fluorescence microscope 
where constant temperature and CO2 levels were maintained. Transmitted light and 
fluorescence images were taken every 45 minutes for 21 hrs. Fluorescence images were 
analyzed by MATLAB [9] to obtain the dynamic profiles of STAT3 and C/EBPβ 
activation and then compared with a model derived from the TF calculation. The scheme 
to calculate the TF data from the GFP data is listed below (Figure 3). 
 
 
Figure 3. Scheme to calculate TF data from GFP data. Relationship between input, output, and 
concentration of transcription factors with GFP-reporter systems. 
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CHAPTER III 
RESULTS 
 
HepG2 reporter cells were cultured as described in Methods and exposed to different 
inflammatory cytokines. Figure 4 is representative of the HepG2 STAT3 cell line. As 
seen in Figure 4, the HepG2 STAT3 cell line exhibited fluorescence even without 
stimulation (baseline fluorescence); however, the level of GFP fluorescence remained 
constant throughout the duration of the experiment (~ 22 hr).  The fluorescence intensity 
of the HepG2 STAT3 cell line stimulated with 100 ng/mL of IL-6 increased after 9 hr. A 
similar trend was observed when HepG2 STAT3 cells were treated with 100 ng/mL of 
OSM. 
 
Figure 5 shows the quantified fluorescence temporal profile of STAT3 clones treated 
with IL-6 (100 ng/mL) and OSM (100 ng/mL). The data show that fluorescence rapidly 
increases after 1 hr of exposure and reaches a maximum after 6 hr. Subsequently, the 
fluorescence levels decrease slightly and reach a steady state value beyond 12 hr of 
stimulation. A similar temporal profile was observed with OSM stimulation; however, 
the GFP levels remained constant after 8 hr without exhibiting any decrease. The 
maximum fluorescence obtained with OSM stimulation was also higher than that 
observed with IL-6 (~ 16-fold vs. 6-fold, respectively). 
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Figure 4. Dynamics of fluorescence intensity with HepG2 STAT3 clone. Images A through I show the 
dynamics of fluorescence intensity with HepG2 cells stably integrated with the STAT3 reporter plasmid 
for 21.75 hrs. Image A: control at 0 hr; Image B: control at 9 hr; Image C: control at 21.75 hr; Image D: 
IL-6( 100 ng/mL) at 0 hr; Image E: IL-6 (100 ng/mL) at 9 hr; Image F: IL-6 (100 ng/mL) at 21.75 hr; 
Image G: OSM (100 ng/mL) at 0 hr; Image H: OSM (100 ng/mL) at 9 hr; Image I: OSM (100 ng/mL) at 
21.75 hr. 
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Figure 5. Dynamics of STAT3 pathway. The dynamics of fluorescence intensity with HepG2 cells stably 
integrated with the STAT3 reporter plasmid and exposed to IL-6 (100 ng/mL) or OSM (100 ng/mL) for 
21.75 h. Left: IL-6 (100 ng/mL); right: OSM (100 ng/mL). Data shown are the average of 4 experiments. 
 
As shown in Figures 6 and 7, the HepG2 C/EBPβ cell line also exhibited baseline GFP 
expression and its fluorescence levels also remained relatively constant throughout the 
experiment. The fluorescence intensity of HepG2 C/EBPβ reporter cells treated with 100 
ng/mL of OSM increased in a manner similar to that seen with the STAT3 reporter cell 
line. However, the maximum fluorescence observed with the C/EBPβ reporter cell line 
upon OSM exposure (~8-fold) was less than that observed with the STAT3 reporter cell 
line (~16-fold). 
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Figure 6. Dynamics of fluorescence intensity with a HepG2 C/EBPβ clone. Images A through F show 
the dynamics of fluorescence intensity with HepG2 cells stably integrated with the C/EBPβ reporter 
plasmid for 21.75 hrs. Image A: control at 0 hr; Image B: control at 9 hr; Image C: control at 21.75 hr; 
Image D: OSM (100 ng/mL) at 0 hr; Image E: OSM (100 ng/mL) at 9 hr; Image F: OSM (100 ng/mL) at 
21.75 hr. 
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Figure 7. Dynamic of C/EBPβ  pathway. The dynamics of fluorescence intensity with HepG2 cells stably 
integrated with the CEBP reporter plasmid and exposed to OSM (100 ng/mL). Data shown are the average 
of 4 experiments. 
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The fluorescence intensity obtained with the HepG2 STAT3 and C/EBPβ cell lines were 
used to determine the validity of a previously developed IL-6 signal transduction model. 
The model predicted profiles of STAT3 and C/EBPβ were used to simulate the temporal 
profile of GFP production under control of an inducible-expression system. The 
simulated profiles were compared to the profiles obtained from the experiments. As 
shown in Figure 8, our data show excellent agreement between the experimental data 
and model predictions, and demonstrate the validity of the previously developed IL-6 
signal transduction model.  
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Figure 8. Comparison of model predictions and experimental data. Solid line is the experimental data 
and dash line is the model prediction. Left: STAT3; right: C/EBPβ. 
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CHAPTER IV 
CONCLUSIONS 
 
The result of the fluorescence microscopy showed that both the HepG2 STAT3 and 
C/EBPβ cell lines expressed GFP in response to the activation of IL-6 and/ or OSM 
through the Jak-STAT3 or Erk-C/EBPβ pathways, respectively. The expression of GFP 
(and hence, the activation of transcription factors) correlated with the specificity of the 
cytokine used. The dynamic profiles of the STAT3 and C/EBPβ activations obtained 
from the fluorescence images were in excellent agreement with the model derived from 
the TF calculation. 
 
Future work will focus on investigating (i) dynamics of the STAT3 and C/EBPβ 
pathways in response to different concentrations and durations of OSM stimulation and 
(ii) dynamics of STAT3 and C/EBPβ upon exposure to additional cytokines such as IL-
10 and IL-1 that are likely to be present along with IL-6. 
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